Search Results (2,405)

Monitoring adolescent team-sport athletes may benefit from combining performance and molecular markers, but empirical evidence supporting this approach in youth team sports remains limited. Objective: Our study investigated molecular and physiological adaptations to seasonal training in elite U18 ice hockey players, focusing on aerobic capacity, salivary cortisol, serum irisin, and cell-free DNA (cfDNA) dynamics. Methods: National-level U18 players were enrolled in our study (n = 23 for cross-sectional analysis, n = 12 longitudinal) during the pre- and early-competition season. Aerobic performance was assessed via graded treadmill VO₂max testing, and the biochemical markers quantified using ELISA-based assays. Results: From pre- to early-season (paired n = 12), VO₂max increased by 10.6% (g = +1.00, p = 0.003) and irisin by 14.7% (g = +0.83, p = 0.010). cfDNA decreased by 60.8% (g = −0.54, p = 0.070; moderate effect, not statistically clear), while cortisol remained stable (+11.3%; p = 0.667). Inter-individual variability increased for VO₂max and irisin and decreased by 82% for cfDNA. Exploratory cross-sectional positional analysis indicated higher irisin levels in forwards and elevated cfDNA in defensemen, although differences did not reach statistical significance. Conclusions: These preliminary findings provide cohort-size limited longitudinal evidence of chronic irisin elevation in ice hockey players and highlight the possibility of combining VO₂max + irisin + cfDNA to assist individualized load/recovery in elite youth ice hockey. Full article

Background: Coronary heart disease (CHD) is the leading cause of death and disability worldwide. The human microbiota, particularly gut bacteria, plays a role in the development of CHD. However, determining the contribution of gut bacteria translocation to systemic circulation in the progression of atherosclerosis remains challenging. Methods and Results: In this exploratory study, we conducted 16S rRNA–based metagenomic analysis to characterize systemic bacterial profiles in a cohort of 27 patients with CHD (9 with severe coronary artery stenosis and 18 with mild to moderate stenosis). We compared microbial diversity between arterial and venous blood and across different blood fractions. For the first time, we observed higher microbial diversity in plasma than in serum. We also identified differences in microbial richness among arterial whole blood, venous whole blood, arterial plasma, venous plasma, arterial serum, and venous serum, with 15, 22, 43, 10, 4, and 3 genera showing significant differences, respectively. Many of the detected blood taxa belonged to genera typically found in intestinal, oral, or skin microbiota, although their precise source cannot be determined from this study. Conclusions: Our study provides preliminary evidence of distinct bacterial profiles between arterial and venous blood fractions in patients with CHD, as determined by 16S rRNA sequencing. These findings should be interpreted with caution given the small sample size and the absence of a healthy control group, and they warrant confirmation in larger, controlled studies. Full article

Background: Schizophrenia is strongly associated with severe oral health deterioration, driven by cognitive deficits, behavioral dysfunction, and medication-related biological changes. Objective: To examine how neurocognitive dysfunction in schizophrenia, particularly cognitive deficits, is associated with poorer oral hygiene control, motivation, and self-regulation, contributes to oral health decline by disrupting everyday oral hygiene behaviors and dental care engagement, and to discuss the implications of this framework for interdisciplinary prevention strategies. Methods: This manuscript follows a narrative review design aimed at conceptually integrating evidence on neurocognitive mechanisms underlying oral health decline in schizophrenia. To identify relevant literature, a targeted search of PubMed/MEDLINE, Scopus, and Web of Science was conducted, covering publications from 2000 to 2025. The search strategy was used to support thematic exploration and conceptual synthesis, rather than to perform a systematic study selection or quantitative evidence aggregation. This narrative review summarizes findings from 90 peer-reviewed studies selected from the available literature. Results: Executive dysfunction, attentional deficits, and low motivation impair routine oral hygiene and delay dental care-seeking. Antipsychotic-induced xerostomia, metabolic disturbances, oxidative stress, immune dysregulation, and oral microbiome dysbiosis accelerate periodontal breakdown and caries progression. These interacting processes generate a self-reinforcing cycle of inflammation, tissue destruction, and treatment avoidance. Epidemiological data show markedly elevated DMFT/DMFS indices and up to a three-fold higher risk of edentulism compared with the general population. Emerging evidence suggests that integrated psychiatric–dental care models may be associated with improvements in oral health and care engagement, although current findings are largely preliminary and based on small or heterogeneous study populations, including related neurocognitive disorders. Conclusions: Unlike existing epidemiological syntheses, this review highlights oral health deterioration in schizophrenia as a functionally mediated consequence of neurocognitive impairment, underscoring the need for preventive approaches aligned with patients’ cognitive and motivational capacities. Full article

Background: In Parkinson’s disease (PD), a higher prevalence of polyneuropathy (PNP) is increasingly recognized, although the causal association is still under debate. In contrast, PNP in atypical parkinsonian syndromes (APS) has been insufficiently addressed, despite preliminary evidence suggesting elevated prevalence. Methods: Nerve conduction studies were performed on 13 patients with multiple system atrophy (MSA) and 9 patients with progressive supranuclear palsy (PSP) at baseline. PNP was diagnosed according to standard electrophysiological criteria after exclusion of common secondary causes. Comprehensive clinical evaluation included motor and non-motor assessments over two years of follow-up. Results: At baseline, PNP was present in 53.8% of MSA patients and 66.7% of PSP patients. MSA patients with PNP showed greater motor symptom severity (UPDRS III score; p = 0.046) and worse cognitive performance (MoCA; p = 0.044) compared to those without PNP. Over two years, a significant reduction in the tibial nerve amplitude was observed exclusively in MSA patients (p = 0.039), paralleling disease progression. Conclusions: This study provides the first longitudinal evaluation of clinical and electrophysiological PNP progression in MSA and PSP. A high comorbidity of PNP in patients with APS could contribute to motor and sensory impairments in these patients. Our findings indicate that PNP progression may reflect disease progression in MSA. Given the limited sample size, larger-scale longitudinal studies are needed to further investigate biomarker potential of PNP in APS and to clarify differences in peripheral nerve involvement between synucleinopathies and tauopathies. Full article

This study explores a circular economy strategy for vineyard residue management through the conversion of pruning biomass into carbonaceous materials by hydrothermal carbonization (HTC) and pyrolysis (PYR), with and without iron (Fe) addition. A preliminary pot-based vegetation experiment was conducted as a screening assay to assess initial plant tolerance and exclude evident phytotoxic effects. Chlorophyll index values in grapevine leaves remained within physiological ranges across treatments and sampling dates, although no consistent treatment-related trends could be established. Overall, the results provide a physicochemical characterization of the carbonaceous materials derived from vineyard residues and demonstrate their initial compatibility with grapevine cultivation under controlled conditions. This work lays the groundwork at the material level for future, more comprehensive studies that integrate long-term soil, plant, and field assessments. Full article

The preservation of cultural heritage within museum environments requires systematic control and monitoring of indoor microclimatic conditions. Over the past four decades, scientific evidence has established the critical role of environmental parameters, including air temperature, relative humidity, light, and airborne pollutants, in the preventive conservation of artifacts. International standards and national guidelines mandate continuous, non-invasive monitoring protocols that integrate conservation requirements with the architectural and operational constraints of historic buildings. Effective implementation necessitates a multidisciplinary approach balancing artifact preservation, human comfort, and building energy efficiency. Recent international recommendations further promote adaptive approaches wherein microclimate thresholds are calibrated to site-specific “historical climate” conditions, derived from minimum one-year baseline datasets. While essential for long-term conservation management, the design and implementation of such monitoring systems present significant technical and logistical challenges. This study presents a replicable methodological approach wherein preliminary surveys and three short-term monitoring campaigns (duration: 2 to 5 weeks) supported design, sensor selection, and spatial deployment and will allow the validation of a long-term continuous monitoring infrastructure (at least one year). These preliminary investigations enabled the following: (1) identification of priority environmental parameters; (2) optimization of sensor placement relative to exhibition layouts and maintenance protocols; and (3) preliminary assessment of microclimate risks in naturally ventilated spaces in the absence of HVAC systems. Full article

Background: Glaucoma is a chronic neurodegenerative disorder characterized by the selective vulnerability of retinal ganglion cells (RGCs), in which mitochondrial dysfunction, redox imbalance, and impaired bioenergetic signaling play central pathogenetic roles. Mitochondrial homeostasis in RGCs critically depends on maintaining intracellular NAD⁺ pools, which support oxidative phosphorylation, sirtuin-mediated deacetylation, and antioxidant gene expression. Nicotinamide riboside (NR), a potent NAD⁺ precursor, and berberine (BBR), an AMPK activator derived from Berberis aristata, have recently emerged as synergistic modulators of mitochondrial metabolism and oxidative stress resistance. Methods: This study retrospectively assessed clinical outcomes associated with combined nutraceutical supplementation of nicotinamide riboside (NR) and berberine (BBR) in patients with primary open-angle glaucoma undergoing stable topical hypotensive therapy. We have included a narrative review in the current literature regarding NAD⁺ biology, AMPK–sirtuin signaling, and oxidative stress responses in retinal ganglion cell (RGC) degeneration. Due to the absence of comparator groups receiving only NR or only berberine in this retrospective cohort, the combined supplementation has been regarded as a biologically complementary strategy, and the potential for synergistic efficacy remains a subject for further investigation. Results: Translationally, a retrospective clinical cohort receiving combined NR and BBR supplementation showed functional stabilization of the visual field and structural preservation of the retinal nerve fiber layer over a six-month follow-up, in line with the proposed mitochondrial protective mechanisms. Conclusions: The clinical trends identified in this retrospective cohort have substantiated the translational significance of NR + BBR supplementation as a potential adjunctive approach in glaucoma management. NAD⁺ repletion and engagement of the AMPK–SIRT–NRF2 pathway may enhance mitochondrial resilience in RGCs. Collectively, these findings offer initial clinical evidence advocating for additional controlled studies on NR + berberine supplementation, while mechanistic interpretations have been derived from the existing literature and are hypothesis-generating. Full article

Background/Objectives: Coenzyme Q10 (CoQ10) is crucial for mitochondrial bioenergetics and redox balance and has been studied in hearing disorders. Its clinical use ranges from genetic mitochondrial deafness to acquired hearing loss associated with oxidative stress. This review aimed to map human clinical evidence on CoQ10 in hearing issues and differentiate its therapeutic roles based on underlying causes. Methods: This review was conducted following the PRISMA Extension for Scoping Reviews (PRISMA-ScR). A systematic search of PubMed, Europe PubMed Central, the Directory of Open Access Journals (DOAJ), and ClinicalTrials.gov was performed. Human clinical studies evaluating CoQ10 or water-soluble CoQ10 formulations with hearing-related outcomes were included and synthesized descriptively. Results: Fourteen studies met the inclusion criteria, including randomized controlled trials, non-randomized clinical studies, case series, and case reports. Two distinct therapeutic roles of CoQ10 emerged: in primary mitochondrial hearing disorders caused by defects in mitochondrial DNA or CoQ10 biosynthesis pathways, CoQ10 acted as a replacement therapy and was consistently linked to stabilization or prevention of progressive sensorineural hearing loss. Conversely, in acquired or age-related conditions—including presbycusis, noise-induced hearing loss, ototoxicity, tinnitus, and sudden sensorineural hearing loss—CoQ10 was used as an antioxidant or neuroprotective supplement, with outcomes showing functional preservation, symptom reduction, or decreased cochlear injury. Internal validity varied across studies: most evidence for replacement therapy was derived from observational designs, and antioxidant applications were mainly supported by small or preliminary clinical trials. Conclusions: The available evidence suggests two distinct clinical roles of CoQ10 in hearing disorders: (i) replacement therapy in genetically defined mitochondrial deafness and (ii) adjunctive antioxidant/neuroprotective use in acquired conditions. Given heterogeneity and limited study quality, further well-designed trials are needed before broad clinical recommendations can be made. Full article

Diabetic ketoacidosis (DKA) remains a life-threatening complication of diabetes mellitus with suboptimal outcomes despite standard management. Emerging evidence suggests that thiamine (vitamin B1) deficiency may play an under-recognized role in DKA pathophysiology and clinical course. This narrative review synthesizes current evidence regarding thiamine deficiency in diabetes and DKA, examining molecular mechanisms, clinical implications, and the rationale for thiamine supplementation as adjunctive therapy. Thiamine deficiency is highly prevalent in diabetes, with plasma concentrations reduced by approximately 75% compared to healthy controls. In DKA specifically, 25–35% of patients present with thiamine deficiency, which often worsens during insulin therapy. The primary mechanism involves hyperglycemia-induced downregulation of renal thiamine transporters (THTR-1 and THTR-2), resulting in 16–24-fold increased renal clearance and massive urinary losses. Thiamine pyrophosphate serves as an essential cofactor for three critical enzymes in glucose metabolism: pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, and transketolase. Deficiency impairs these pathways, causing pyruvate accumulation with conversion to lactate (resulting in lactic acidosis), compromised TCA cycle function (reducing ATP production by 40–48%), and decreased NADPH generation (increasing oxidative stress). Clinical manifestations include persistent metabolic acidosis despite standard therapy, myocardial dysfunction with elevated cardiac biomarkers, neurological impairment, and prolonged recovery times. Cellular studies demonstrate that thiamine supplementation significantly improves mitochondrial oxygen consumption in DKA patients. The high prevalence of thiamine deficiency in DKA, compelling biochemical rationale, excellent safety profile, and preliminary mechanistic evidence support the urgent need for large-scale randomized controlled trials examining thiamine supplementation to definitively establish efficacy, optimal dosing, and patient selection criteria. Full article

Background: Interpreting short tandem repeat (STR) profiles from low-template DNA (LT-DNA) requires consideration of the stochastic phenomena that can affect the reliability of genotypes. Although several probabilistic genotyping tools have been developed to model such uncertainties, most have only been used for direct comparisons between persons of interest and crime scene samples. Their application to kinship testing involving LT-DNA has received comparatively little attention. Methods: We evaluated the performance of two PGS, EuroForMix (EFM) and EFMrep, which support alternative hypotheses with relatedness, by comparing them with a standard paternity testing software (Familias) in 33 paternity cases involving LT-DNA samples categorised as ‘mildly’ (MD) or ‘highly’ (HD) degraded based on the quality of the STR profiles. The samples included formalin-fixed paraffin-embedded tissues, bone specimens, and stains collected from personal items. Pedigrees with (‘trio’) and without (‘duo’) maternal information were considered. Results: In MD and HD duos, the likelihood ratios (LRs) obtained with EFMrep were significantly higher compared to other software. In trios, Familias produced significantly higher LRs than PGS for MD samples, whereas the three software performed comparably for HD samples. Notably, in HD trios, EFMrep was the software most likely to maximise LR values, which were above 10,000 in 60% of the cases, compared to 50% of EFM and 40% of Familias. Conclusions: These findings provide preliminary evidence of the potential and limitations of using PGS for kinship assessments involving LT-DNA specimens. Full article

Objective: This study aimed to systematically evaluate the effects of hypoxic exercise at different oxygen concentrations on body composition, glucose metabolism, and lipid metabolism in individuals with obesity, and to explore potential optimal oxygen concentration ranges to inform personalized hypoxic exercise prescriptions. Methods: We searched databases including the Cochrane Library, PubMed, Web of Science, Embase, and CNKI for randomized controlled trials and pre-post studies on hypoxic exercise interventions in obese populations published before 30 June 2025. A network meta-analysis was performed using Stata 18.0 software to assess the effects of various oxygen concentrations on BMI, FBG, FINS, HOMA-IR, TG, LDL-C, and HDL-C. Subgroup analyses were conducted to explore sources of heterogeneity. Results: Fourteen studies with a total sample size of 189 participants were included. The meta-analysis revealed that exercise in a moderate hypoxic environment (12–14% FiO₂) significantly reduced BMI, FBG, TG, and LDL-C. Notably, hypoxic exercise did not show a statistically significant effect on HDL-C. In contrast, a higher oxygen concentration (≥15% FiO₂) was more effective for improving FINS and HOMA-IR. Conclusion: Hypoxic exercise can significantly improve the body composition, glucose metabolism and lipid metabolism indicators of obese people. Tailored exercise in specific hypoxic environments provides preliminary evidence for a non-pharmacological intervention strategy in obesity management. Full article

Background: Radon exposure has been recognised as a risk factor for developing lung cancer and other health issues. The mutagenic changes associated with long-term radon exposure take 10–30 years to manifest, which may lead to a lower observed incidence of lung cancer in children. Children are more vulnerable to radon exposure and its effects due to their smaller lung capacity and faster breathing rates, resulting in greater radon inhalation. Objective: The aim of the study is to present current evidence on the association between radon exposure and health effects among children. Methodology: We conducted a systematic review of the available literature on radon exposure and its health impacts, focusing on children. A preliminary literature scoping was conducted in CINAHL, PubMed, Google Scholar, and ScienceDirect. Some of the search terms included: “children” OR “health” OR “implications” OR “radon” OR “exposure”. Subsequently, a comprehensive search was conducted, covering quantitative studies in EBSCOhost across all selected databases. The review adhered to the 27-item PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklist. The quality of the evidence gathered was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool. The study was registered with PROSPERO under the ID: CRD420251269394. The review analysed 26 studies, all published between 1994 and 2025. Results: The incidence of lung cancer was projected to increase with childhood radon exposure, with statistical significance (OR per radon 100 Bq/m³ = 1.16; 1.05–1.31). Certain biological markers were associated with childhood long-term radon exposure: IL-5 (13.4%; 95% CI: 0.4–2.8; p = 0.044). Conclusions: Childhood radon exposure, although rarely enough to cause overt malignancy, contributes cumulatively to lifetime lung cancer risk and causes detectable biological markers. Full article

Ajuga iva (L.) Schreb. is traditionally used in North African ethnomedicine for the management of inflammation, pain, and fever. The present study aimed to characterize the phytochemical profile of the hydroalcoholic extract of its aerial parts and to evaluate its anti-inflammatory, analgesic, and antipyretic activities using established in vivo models. Preliminary phytochemical screening confirmed the presence of major classes of secondary metabolites, including polyphenols, flavonoids, tannins, and glycosidic compounds. Quantitative assays revealed appreciable levels of total phenolics (26.3 ± 1.2 mg GAE/g extract) and flavonoids (13.5 ± 0.9 mg QE/g extract). In vivo pharmacological evaluation demonstrated significant biological activities, with the highest tested dose (400 mg/kg) producing a marked inhibition of carrageenan-induced paw edema (44.9%), comparable to acetylsalicylic acid. At the same dose, the extract showed pronounced analgesic activity in the acetic acid-induced writhing test, with an inhibition rate of 64.2%, and a significant antipyretic effect in the brewer’s yeast-induced fever model, as evidenced by a reduction in rectal temperature. In parallel, molecular docking was employed as an exploratory, hypothesis-generating in silico approach to investigate potential interactions between selected phenolic constituents identified in A. iva and cyclooxygenase-2 (COX-2). Several compounds, including rosmarinic acid, rutin, and apigenin-7-O-glucoside, displayed favorable predicted binding affinities and interactions with key residues of the COX-2 active site. It should be emphasized that molecular docking was used solely as a hypothesis-generating in silico tool and does not constitute direct biochemical evidence of COX-2 inhibition. Overall, these findings indicate that the hydroalcoholic extract of Ajuga iva exhibits notable anti-inflammatory, analgesic, and antipyretic activities in vivo. The in silico docking results provide supportive, predictive molecular insights that may help rationalize the observed bioactivities and encourage further biochemical and mechanistic investigations into this traditionally used medicinal plant. Full article

Background/Objectives: This pilot study explored the applicability and preliminary clinical outcomes of cognitive stimulation therapy (CST), an evidence-based cognitive intervention for people with mild and moderate dementia, in elderly individuals with concurrent dementia and visual impairment. Methods: Seven participants received 14 group CST sessions. Their cognitive and language functions were measured and compared pre-/post-therapy. Results: The treatment adherence was satisfactory. Significant improvements in various cognitive domains and language measures were observed after therapy. Conclusions: The findings suggest that CST can be applied to visually impaired individuals with dementia with seemingly positive outcomes in various cognitive domains. Further studies with a larger sample with an emphasis on multisensory stimulation to facilitate therapy delivery are warranted. Full article

Plant polyphenols, particularly flavonoids, are prominent bioactives in preventive/complementary therapeutic strategies. This article analyzes how some polyphenols can mitigate oxidative stress and inflammation. These processes are involved in cardiovascular disease, cancer, neurodegeneration, and metabolic disorders. Polyphenols are explored through the integration of direct antioxidant chemistry (radical scavenging via hydrogen atom transfer/single-electron transfer/metal chelation), redox signaling (Keap1–Nrf2/ARE and inflammatory pathways), endogenous antioxidant enzyme systems, and mitochondrial quality control. Unlike previous descriptive reviews, a novel aspect of this manuscript is its evidence-based synthesis, fully supported by structured summary tables that explicitly detail limitations, contradictions, and context dependencies in in vitro, in vivo, and human studies, and identify clinically interpretable endpoints for their application. We describe relevant flavonoids and dietary sources, along with functional outcomes in cardiometabolic–cognitive/neuroprotective–immunometabolic contexts. We integrate representative clinical interventions and nutraceutical applications, highlighting where reported benefits are supported and where the evidence is preliminary. Bioavailability, microbiota-driven biotransformation, and dose realism are considered the primary determinants of in vivo relevance, rather than secondary or descriptive considerations. Future research should prioritize standardized exposure and metabolite profile, dose-appropriate interventions, harmonized clinical endpoints, and stratification strategies that account for microbiome-driven interindividual variability to improve reproducibility and inform nutraceutical and therapeutic use. Full article